Biocon Biologics to Acquire Viatris’ Biosimilars Assets in USD 3.335 billion
Biocon Biologics Limited’s (BBL) acquisition of Viatris’ rights in biosimilars assets, creates a unique global, vertically ...
Read more
Tag: biocon
Biocon receives approval of its ANDA for Posaconazole Delayed-Release tablets from the US FDA
Biocon Pharma Limited, a subsidiary of Biocon Limited, received approval of its ANDA for Posaconazole Delayed-Release ...
Read more
Biocon appoints Indranil Sen as Chief Financial Officer
Biocon appointed Mr. Indranil Sen as the Chief Financial Officer and Key Managerial Personnel of the ...
Read more
Biocon Q4FY21 Revenue at Rs 2,044 Cr, Up 26%; EBITDA at Rs 641 Cr; Up 68%
Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated ...
Read more
Biocon Biologics’ New Monoclonal Antibodies Manufacturing Facility Wins Award
Biocon Biologics Ltd., announced today that it has been awarded with the 2021 Facility of the ...
Read more
Kiran Mazumdar-Shaw Joins Board of Trustees of Memorial Sloan Kettering Cancer Center, U.S.
Kiran Mazumdar-Shaw has been appointed to the Board of Trustees of Memorial Sloan Kettering Cancer Center ...
Read more“Biocon Biologics and Viatris Receive European Commission Approval for Biosimilar Bevacizumab
Biocon Biologics Ltd., a subsidiary of Biocon Ltd, has announced that Abevmy® 100 & 400 mg, ...
Read moreBiocon Pharma Limited receives GMP compliance certificate from MHRA, UK
Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good ...
Read moreBiocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil
Biocon Ltd today announced a partnership between Biocon Pharma Limited, a wholly owned subsidiary of Biocon ...
Read more